Cargando…

Influence of disease prevalence on cost-effectiveness of magnetic resonance imaging versus coronary angiography combined with fractional flow reserve testing

Detalles Bibliográficos
Autores principales: Moschetti, Karine, Favre, David, Pinget, Christophe, Pilz, Guenter, Petersen, Steffen E, Wagner, Anja, Wasserfallen, Jean-Blaise, Schwitter, Juerg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044054/
http://dx.doi.org/10.1186/1532-429X-16-S1-O98
_version_ 1782319071627313152
author Moschetti, Karine
Favre, David
Pinget, Christophe
Pilz, Guenter
Petersen, Steffen E
Wagner, Anja
Wasserfallen, Jean-Blaise
Schwitter, Juerg
author_facet Moschetti, Karine
Favre, David
Pinget, Christophe
Pilz, Guenter
Petersen, Steffen E
Wagner, Anja
Wasserfallen, Jean-Blaise
Schwitter, Juerg
author_sort Moschetti, Karine
collection PubMed
description
format Online
Article
Text
id pubmed-4044054
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40440542014-06-17 Influence of disease prevalence on cost-effectiveness of magnetic resonance imaging versus coronary angiography combined with fractional flow reserve testing Moschetti, Karine Favre, David Pinget, Christophe Pilz, Guenter Petersen, Steffen E Wagner, Anja Wasserfallen, Jean-Blaise Schwitter, Juerg J Cardiovasc Magn Reson Oral Presentation BioMed Central 2014-01-16 /pmc/articles/PMC4044054/ http://dx.doi.org/10.1186/1532-429X-16-S1-O98 Text en Copyright © 2014 Moschetti et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Oral Presentation
Moschetti, Karine
Favre, David
Pinget, Christophe
Pilz, Guenter
Petersen, Steffen E
Wagner, Anja
Wasserfallen, Jean-Blaise
Schwitter, Juerg
Influence of disease prevalence on cost-effectiveness of magnetic resonance imaging versus coronary angiography combined with fractional flow reserve testing
title Influence of disease prevalence on cost-effectiveness of magnetic resonance imaging versus coronary angiography combined with fractional flow reserve testing
title_full Influence of disease prevalence on cost-effectiveness of magnetic resonance imaging versus coronary angiography combined with fractional flow reserve testing
title_fullStr Influence of disease prevalence on cost-effectiveness of magnetic resonance imaging versus coronary angiography combined with fractional flow reserve testing
title_full_unstemmed Influence of disease prevalence on cost-effectiveness of magnetic resonance imaging versus coronary angiography combined with fractional flow reserve testing
title_short Influence of disease prevalence on cost-effectiveness of magnetic resonance imaging versus coronary angiography combined with fractional flow reserve testing
title_sort influence of disease prevalence on cost-effectiveness of magnetic resonance imaging versus coronary angiography combined with fractional flow reserve testing
topic Oral Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044054/
http://dx.doi.org/10.1186/1532-429X-16-S1-O98
work_keys_str_mv AT moschettikarine influenceofdiseaseprevalenceoncosteffectivenessofmagneticresonanceimagingversuscoronaryangiographycombinedwithfractionalflowreservetesting
AT favredavid influenceofdiseaseprevalenceoncosteffectivenessofmagneticresonanceimagingversuscoronaryangiographycombinedwithfractionalflowreservetesting
AT pingetchristophe influenceofdiseaseprevalenceoncosteffectivenessofmagneticresonanceimagingversuscoronaryangiographycombinedwithfractionalflowreservetesting
AT pilzguenter influenceofdiseaseprevalenceoncosteffectivenessofmagneticresonanceimagingversuscoronaryangiographycombinedwithfractionalflowreservetesting
AT petersensteffene influenceofdiseaseprevalenceoncosteffectivenessofmagneticresonanceimagingversuscoronaryangiographycombinedwithfractionalflowreservetesting
AT wagneranja influenceofdiseaseprevalenceoncosteffectivenessofmagneticresonanceimagingversuscoronaryangiographycombinedwithfractionalflowreservetesting
AT wasserfallenjeanblaise influenceofdiseaseprevalenceoncosteffectivenessofmagneticresonanceimagingversuscoronaryangiographycombinedwithfractionalflowreservetesting
AT schwitterjuerg influenceofdiseaseprevalenceoncosteffectivenessofmagneticresonanceimagingversuscoronaryangiographycombinedwithfractionalflowreservetesting